- Home
- DNLI vs SFNC Comparison
DNLI vs SFNC Comparison
Compare DNLI & SFNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DNLI | SFNC |
|---|---|---|
| Founded | 2013 | 1903 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.3B |
| IPO Year | 2017 | 2001 |
Fundamental Metrics
Financial Performance| Metric | DNLI | SFNC |
|---|---|---|
| Price | $23.11 | $23.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 6 |
| Target Price | ★ $34.33 | $22.17 |
| AVG Volume (30 Days) | ★ 1.9M | 1.7M |
| Earning Date | 05-06-2026 | 04-16-2026 |
| Dividend Yield | N/A | ★ 4.05% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.47 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2,607.90 |
| Revenue Next Year | $408.85 | $4.15 |
| P/E Ratio | ★ N/A | $48.96 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.58 | $17.00 |
| 52 Week High | $27.30 | $23.91 |
Technical Indicators
Market Signals| Indicator | DNLI | SFNC |
|---|---|---|
| Relative Strength Index (RSI) | 45.21 | 59.65 |
| Support Level | $18.27 | $22.14 |
| Resistance Level | $23.27 | $23.65 |
| Average True Range (ATR) | 1.38 | 0.51 |
| MACD | -0.39 | -0.02 |
| Stochastic Oscillator | 17.58 | 64.19 |
Price Performance
Historical ComparisonAbout DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
About SFNC Simmons First National Corporation
Simmons First National Corp is a financial holding company. The company through its subsidiaries is engaged in providing banking services including consumer, real estate and commercial loans, checking, savings and time deposits. Its loan portfolio comprises construction, single-family residential and commercial loans; non-real estate loans, nonaccrual and past due loans; and credit card loans, student loans and other consumer loans. It also offers various products and services such as trust services, investments, agricultural finance lending, equipment lending, insurance, consumer finance and small business administration lending. The business activity of the firm is functioned through the region of the United States.